MERRIMACK PHARMACEUTICALS INC Quarterly Other Assets, Noncurrent in USD from Q4 2011 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Merrimack Pharmaceuticals Inc quarterly Other Assets, Noncurrent history and growth rate from Q4 2011 to Q1 2024.
  • Merrimack Pharmaceuticals Inc Other Assets, Noncurrent for the quarter ending March 31, 2024 was $3K, a 57.1% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $3K -$4K -57.1% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $4K -$4K -50% Dec 31, 2023 10-Q 2024-05-15
Q3 2023 $5K -$4K -44.4% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $6K -$4K -40% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $7K -$18K -72% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $8K -$58K -87.9% Dec 31, 2022 10-K 2024-03-07
Q3 2022 $9K -$99K -91.7% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $10K -$139K -93.3% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $25K -$166K -86.9% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $66K -$166K -71.6% Dec 31, 2021 10-K 2023-03-09
Q3 2021 $108K -$166K -60.6% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $149K -$166K -52.7% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $191K -$1.18M -86% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $232K -$1.16M -83.3% Dec 31, 2020 10-K 2022-03-09
Q3 2020 $274K -$2.17M -88.8% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $315K -$2.17M -87.3% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $1.37M -$1.15M -45.7% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $1.39M -$1.35M -49.3% Dec 31, 2019 10-K 2021-03-10
Q3 2019 $2.44M -$2.13M -46.5% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $2.48M -$2.15M -46.4% Jun 30, 2019 10-Q 2019-07-17
Q1 2019 $2.52M -$2.03M -44.5% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $2.74M -$1.84M -40.2% Dec 31, 2018 10-K 2020-03-12
Q3 2018 $4.57M Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $4.63M +$4.61M +17063% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $4.55M +$4.52M +16744% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $4.59M +$4.56M +16893% Dec 31, 2017 10-K 2019-03-06
Q2 2017 $27K $0 0% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $27K $0 0% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $27K $0 0% Dec 31, 2016 10-K 2018-03-12
Q3 2016 $27K -$98K -78.4% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $27K -$105K -79.5% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $27K -$112K -80.6% Mar 31, 2016 10-Q 2016-05-02
Q4 2015 $27K +$2K +8% Dec 31, 2015 8-K 2017-12-15
Q3 2015 $125K -$27K -17.8% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $132K -$28K -17.5% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 $139K -$28K -16.8% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 $25K -$150K -85.7% Dec 31, 2014 10-K 2016-02-26
Q3 2014 $152K -$29K -16% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $160K +$129K +416% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 $167K +$133K +391% Mar 31, 2014 10-Q 2014-05-06
Q4 2013 $175K -$893K -83.6% Dec 31, 2013 10-K 2015-02-27
Q3 2013 $181K -$874K -82.8% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 $31K +$8K +34.8% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 $34K +$11K +47.8% Mar 31, 2013 10-Q 2013-05-13
Q4 2012 $1.07M +$1.05M +4543% Dec 31, 2012 10-K 2014-03-04
Q3 2012 $1.06M Sep 30, 2012 10-Q 2012-11-14
Q2 2012 $23K Jun 30, 2012 10-Q 2012-08-14
Q1 2012 $23K Mar 31, 2012 10-Q 2012-05-15
Q4 2011 $23K Dec 31, 2011 10-K 2013-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.